The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland

CompletedOBSERVATIONAL
Enrollment

60,000

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

March 20, 2025

Study Completion Date

March 20, 2025

Conditions
Artificial IntelligenceBreast DiseasesNeoplasmsBreast Neoplasms
Interventions
DEVICE

AI cancer detection system

The AI system Transpara (Screenpoint Medical, The Netherlands) will be implemented for triaging two-image mammography examinations based on the probability of malignancy. Transpara assigns a score from 1 to 10 to each examination, indicating the risk of malignancy. A score between 1 and 7 indicates a low risk of cancer, 8-9 indicates an intermediate and 10 an elevated risk of cancer. Examinations with an AI score between 1 and 7 will be reviewed by only one radiologist, while examinations with an AI score \> 7 will be double-reviewed as normal.

Trial Locations (1)

Unknown

Region Östergötland, Linköping

All Listed Sponsors
lead

Ostergotland County Council, Sweden

OTHER